Supplementary Table S1 from Cell-Free Urine and Plasma DNA Mutational Analysis Predicts Neoadjuvant Chemotherapy Response and Outcome in Patients with Muscle-Invasive Bladder Cancer

<p>Summarized metrics for WES data</p>

Enregistré dans:

Détails bibliographiques
Auteur principal:	Emil Christensen (15054394) (author)
Autres auteurs:	Iver Nordentoft (15054397) (author), Karin Birkenkamp-Demtröder (15054400) (author), Sara K. Elbæk (15054403) (author), Sia V. Lindskrog (15054406) (author), Ann Taber (15054409) (author), Tine G. Andreasen (15054412) (author), Trine Strandgaard (15054415) (author), Michael Knudsen (15054418) (author), Philippe Lamy (15054421) (author), Mads Agerbæk (15054424) (author), Jørgen B. Jensen (15054427) (author), Lars Dyrskjøt (15054430) (author)
Publié:	2025
Sujets:	Cancer Cancer Detection and Diagnosis Therapeutic Research and Development Methods and Technology Biomarkers Prognostic biomarkers Genitourinary Cancers Bladder cancer Liquid Biopsy Translational Research
Tags:	Ajouter un tag Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires